Global Next Generation Sequencing Market: Latest Trends, Opportunities and Driver
According to a new report published by Reports Monitor titled, “Global Next Generation Sequencing Market, Growth Opportunities, Innovations and Forecast, 2018-2025,” the Next Generation Sequencing Market was valued at XX million in 2016, and is projected to reach at XX million by 2025, growing at a CAGR of XX% from 2018 to 2025.
DNA strands to get sequenced simultaneously, through massive parallelization by the technique called next generation technique. Next generation sequencing is also called as high-throughput sequencing is a gene sequencing technology that has changed the genome research. Due to its high capability to sequence DNA, the technology has drawn attention in research investment. High accuracy, speed, low cost and accurate results even from low sample input are the major advantages the technology offers over other traditional methods.
Increasing application of NGS in diagnostics and genome mapping, technological advancements and increasing demand for accurate technology are some of the major factors driving the market growth. The technology is growing at a rapid rate due to increasing acceptance and approvals in clinical applications as it allows scanning of a targeted genome or whole genomes in lesser time.
This report provides a detailed analysis of Next Generation Sequencing Market, which includes current industry situations such as market size, growth and demands, market outlook, major players with their key strategies such as investment, mergers and acquisitions, value chain analysis and porter’s analysis. It covers the market canvas and the growth opportunities in the coming years. The report has been made with an in-depth analysis along with important inputs from the various industry experts. The research is carried out with both extensive primary and secondary data sources supported with either bottom up or top down approach.
Te global next generation sequencing market is segmented on the basis of product, technology, application and end user. On the basis of product, the market is segmented into Reagents & Consumables and Instruments & Service. On the basis of technology, the market is segmented into Whole Genome Sequencing, Targeted Re-Sequencing, Whole Exome Sequencing, Chip Sequencing and others. On the basis of application, the market is segmented into Drug Discovery, Genetic Screening, Diagnostics, Agricultural and Animal Research and Others. On the basis of end user, the market is segmented into Biotechnology and Pharmaceutical companies, Hospitals and Healthcare Institutions, Research Institutions and Others.
The Global Next Generation Sequencing market is majorly studied across four regions: North America, Europe, Asia Pacific and LAMEA (Latin America, Middle East and Africa). Increased awareness of next generation sequencing and its application, reduced cost of this process, the presence of a majority of respondents for academic & clinical use drives the growth of the market. Rising population, developing healthcare infrastructure and increasing residual and per capita income are responsible for the growth of the market in Asia-Pacific region.
The major key players operating in the market are: Thermo Fisher Scientific, Illumina, Inc., Beijing Genomics Institute, Pacific Biosciences of California, Inc., Agilent Technologies, Inc., Qiagen N.V., Roche Holding AG, Perkinelmer, Inc., PierianDx and Genomatix GmbH.
We at Garner Insights.com provide a comprehensive analysis by providing in-depth reports of the various market verticals. Our Mission is to provide a detailed analysis of the vast markets worldwide backed by rich data. Decision makers can now rely on our well-defined data gathering methods to get the correct and accurate market forecasting along with detailed analysis.